Bayer Aktiengesellschaft’s short interest rose 183.4% in the first half of September. At the end of August, 127,301 shares were sold short. By September 15, that total had reached 360,790 shares, signaling a more bearish outlook among some market participants.
The increase came despite positive analyst ratings. MarketBeat says the consensus rating remains Buy. Bayer recently reported quarterly earnings per share of $0.29, beating analyst estimates. The rise in short interest suggests some investors remain concerned about potential headwinds.